Key opinion leaders analyze EULAR 2024 updates on gout, chronic inflammation's systemic impact, and gout-chronic kidney disease (CKD) connections, while examining urate-lowering therapies for gout management, particularly in patients with CKD.
Back
Moving Beyond the Joint: Unraveling Gout's Systemic and Renal Implications
Key opinion leaders analyze EULAR 2024 updates on gout, chronic inflammation's systemic impact, and gout-chronic kidney disease (CKD) connections, while examining urate-lowering therapies for gout management, particularly in patients with CKD.
Moving Beyond the Joint: Unraveling Gout's Systemic and Renal Implications
Episodes
All
All
Key opinion leaders analyze EULAR 2024 updates on gout, chronic inflammation's systemic impact, and gout-chronic kidney disease (CKD) connections, while examining urate-lowering therapies for gout management, particularly in patients with CKD.
Advertisement
Advertisement
Trending on HCPLive
1
Sugar-Sweetened Beverages Associated With Increased Gastric Cancer Risk, With Andrew Chan, MD, MPH
2
Metabolic Dysfunction May Explain Sugar-Sweetened Beverage–Gastric Cancer Link, With Andrew Chan, MD, MPH
3
Ketamine, Psychedelics Share Neuroimmune Signature in TRD
4
How ABCG2 Inhibition Could Change EPP Disease Management
5